Clinical Trials on RAS Mutation

Total 2182 results

Adlai Nortye Biopharma Co., Ltd.

Recruiting

Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations

RAS Mutation | Solid Tumors (Phase 1)

United States
Adlai Nortye Biopharma Co., Ltd.

Not yet recruiting

A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression

RAS Mutation | Solid Tumor (Phase I) | CEACAM5

Australia
Genfleet Therapeutics (Shanghai) Inc.

Not yet recruiting

A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation

Pancreatic Ductal Adenocarcinoma | Advanced Solid Tumors Cancer | RAS Mutation

China, Australia
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Study of HRS-2329 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications

Advanced Solid Tumors Harboring RAS Mutations or Amplifications

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications

Advanced Solid Tumors Harboring RAS Mutations or Amplifications

China

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe